GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹24 Cr | ₹6.64 Cr | ₹-1.44 Cr | ₹-1.67 Cr | ₹1.88 Cr |
What is the latest Cash Flow from Operating Activities ratio of GENNEX LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹24 Cr |
Mar2022 | ₹6.64 Cr |
Mar2021 | ₹-1.44 Cr |
Mar2020 | ₹-1.67 Cr |
Mar2019 | ₹1.88 Cr |
How is Cash Flow from Operating Activities of GENNEX LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹24 Cr | 256.78 | |
Mar2022 | ₹6.64 Cr | Positive | |
Mar2021 | ₹-1.44 Cr | Negative | |
Mar2020 | ₹-1.67 Cr | Negative | |
Mar2019 | ₹1.88 Cr | - |
Compare Cash Flow from Operating Activities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹333.1 Cr | -11.6% | -19.4% | 139.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,071.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,300.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,202.0 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,035.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -11.6% |
-19.4% |
139.7% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses